探索大在酒精性肝病中的治疗潜力:一个网络药理学和实验验证研究
Siqi Gao1, Tingting Gao1, Lizheng Li1
1Department of Vascular Surgery, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Genes & nutrition
|July 23, 2024
概括
化合物可以通过减少炎症和改善乙醇代谢来抑制酒精性肝病 (ALD). 这项研究使用了网络药理学和分子对接来确定ALD治疗的潜在治疗机制.
科学领域:
- 综合生物学 综合生物学
- 计算药理学是一种计算药理学.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 酒精性肝病 (ALD) 是一个重要的全球健康问题,有可能发展为肝细胞癌.
- 了解ALD背后的分子机制对于开发有效的治疗策略至关重要.
研究的目的:
- 预测大中的活性化合物并阐明它们在抑制酒精性肝病 (ALD) 发展的机制.
- 通过网络药理学和分子对接,识别的潜在治疗标和活性成分,用于ALD治疗.
主要方法:
- 从TCMSP,TCM-ID和ETCM数据库中选大的活性成分和标.
- 从DisGeNET,GeneCards和DigSeE数据库中识别ALD疾病的目标.
- 网络建设,路径丰富分析 (GO,KEGG),分子对接和使用GEO数据库的人类测序数据的验证.
主要成果:
- 通过整合大和ALD目标来识别83个基因.
- 网络药理学发现得到了酒精诱导的ALD小鼠模型的支持.
- 大可以通过减轻炎症和促进乙醇代谢来抑制ALD的进展.
结论:
- 这项研究提供了关于大抑制ALD的治疗机制的见解.
- 已识别的活性成分为ALD治疗开发提供了有前途的途径.
- 强调植物疗法的重要性在管理肝脏疾病,如ALD.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129


